Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Peerj|December 18, 2020
Identification and characterization of critical genes associated with tamoxifen resistance in breast cancerKai Zhang, Kuikui Jiang, Ruoxi Hong, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 23, 2020
Defect of SLC38A3 promotes epithelial-mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinomaRui Liu, Ruoxi Hong, Yan Wang, et al.
Gland Surgery|March 14, 2023
Construction and validation of a macrophage polarization-related prognostic index to predict the overall survival in patients with early-stage triple-negative breast cancerHanjia Luo, Ruoxi Hong, Yadong Xu, et al.
Cancer Communications (London, England)|May 12, 2020
Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real-world data analyses and experience of one centerQianyi Lu, Kaping Lee, Fei Xu, et al.
Translational Cancer Research|February 4, 2022
Local treatment for liver oligometastases in breast cancer patients: identification of prognostic factors and exploration of appropriate treatment strategyKuikui Jiang, Wen Xia, Ruoxi Hong, et al.
Medicine|May 2, 2015
Efficacy of oral Etoposide in pretreated metastatic breast cancer: a multicenter phase 2 studyPeng Yuan, Lijun Di, Xiaohui Zhang, et al.
Cancer Management and Research|August 28, 2018
Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysisKai Zhang, Ruoxi Hong, Fei Xu, et al.
Theranostics|September 28, 2022
The metabolic genomic atlas reveals potential drivers and clinically relevant insights into the etiology of esophageal squamous cell carcinomaXuesong Liu, Ruoxi Hong, Peina Du, et al.
International Journal of Surgery (London, England)|December 22, 2025
Extracellular matrix-derived mechanical force induces CDK4/6 inhibitor resistance by inhibiting NEK10 dependent cell cycle regulation in breast cancerCong Li, Jian Wang, Yuming Jin, et al.
Oncotarget|July 16, 2016
SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancerAnjie Zhu, Peng Yuan, Feng Du, et al.
Pageof 6